A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced HER2 Negative Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Mitoxantrone Hydrochloride Liposome Injection
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.